4.4 Article

HIV-1 Cell-to-Cell Transmission and Antiviral Strategies: An Overview

Journal

CURRENT DRUG TARGETS
Volume 17, Issue 1, Pages 65-75

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945011701151217105638

Keywords

Broadly neutralizing antibodies; cell-to-cell transmission; cART; HIV-1; HIV-1 accessory proteins; virological synapse

Funding

  1. French Agence Nationale de Recherche sur le SIDA et les Hepatite Virales (ANRS)
  2. SI-DACTION
  3. AREVA
  4. Vaccine Research Institute (Creteil, France)
  5. Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (IBEID) programme
  6. Institut Pasteur

Ask authors/readers for more resources

HIV-1 replicates by infecting new target cells either as cell-free viral particle or, much more efficiently, via cell-to-cell viral transmission. Cell-mediated viral spread, in which the infected cell directly transfers the viral particles to target cells via cell-cell contacts, in vitro is up to three orders of magnitude more efficient than transmission mediated by cell-free viral particles. Because of its potency, it has been suggested that current antiretroviral treatments could be less effective in blocking cell-to-cell viral transmission than cell-free. In this review, I will present an overview of the drug-based antiretroviral approaches as well as how the recently identified class of anti-HIV-1 broadly neutralizing antibodies could become part of an effective anti-viral strategy. I will discuss how both treatment strategies can be guided by our consideration that cell-to-cell HIV-1 spread is a major route of viral spread also in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available